Related Experiment Video
Updated: Jun 7, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
[Epidemiology of heart failure]
Dorothée Malaquin1, Christophe Tribouilloy
1Service de cardiologie B, hôpital Sud, CHU d'Amiens, 80054 Amiens Cedex 1. malaquin.dorothee@chu-amiens.fr
Insights
Heart failure is a growing epidemic, particularly in aging populations. Optimizing therapies and preventive strategies are crucial to reduce its significant morbidity and mortality.
Area of Science:
- Cardiology
- Public Health
- Geriatrics
Context:
- Heart failure (HF) prevalence is rising globally due to improved cardiovascular care and an aging population.
- HF affects approximately 9% of individuals aged 80-89, with a mean onset age of 75.
- Diastolic heart failure constitutes 40-55% of all HF cases, with hypertension and ischemic cardiomyopathy as primary causes, and diabetes increasingly implicated.
Purpose:
- To highlight the escalating public health challenge posed by heart failure.
- To underscore the significant morbidity, mortality, and economic burden associated with heart failure.
- To emphasize the need for optimized therapeutic and preventive strategies.
Summary:
- Heart failure is a major and growing health problem, often termed a 'new epidemic,' with increasing prevalence in aging Western populations.
- The condition carries a poor prognosis, with a five-year mortality rate exceeding 50%, and results in substantial hospitalizations and healthcare costs.
- Addressing heart failure requires optimizing pharmacologic and device therapies, alongside enhancing preventive measures like educational programs and multidisciplinary management.
Impact:
- Reduced heart failure-related morbidity and mortality through optimized treatment and prevention.
- Decreased healthcare expenditures associated with heart failure hospitalizations and management.
- Improved patient outcomes and quality of life via comprehensive, etiology-focused care.
Abstract:
Heart failure is a common pathology sometimes considered as a "new epidemic". Its prevalence is increasing over the years since the cardiovascular management of patients is improving, and the Western population is aging. Prevalence is estimated to 9% in the 80-89 year-old patients, with a mean age of 75 at the onset of heart failure. The proportion of "diastolic heart failure" is about 40 to 55% of the total number of heart failure patients. Hypertension and ischemic cardiomyopathy are the most frequent aetiologies, but diabetes plays an increasing role. Prognosis of heart failure remains poor. Thus, five-year mortality rate is decreasing but remains higher than 50% in recent years. Furthermore, heart failure leads to more than 150 000 hospitalizations in France and the the cost of heart failure represents 1% of the total health expenditures. Thus, heart failure is a major and growing health problem. To reduce morbidity and mortality, we need to optimize therapy (both, pharmacologic and device therapy) and improve preventive measures, such as educational programs and multidisciplinary management in order to treat not only the disease itself but its aetiology, as well.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure VII: Nursing Interventions